Effect of helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine

Hepato-Gastroenterology

Volumn 54, Issue 76, 2007, Pages 1280-1284

  Koike, Tomoyuki ^a   Ohara, Shuichi ^a   Sekine, Hitoshi ^a   Kawamura, Masashi ^a   Abe, Yasuhiko ^a   Inomata, Yoshifumi ^a   Iijima, Katsunori ^a   Imatani, Akira ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acid inhibition; Famotidine; H2 receptor antagonist; Helicobacter pylori; Intragastric pH metry; Lafutidine

Indexed keywords

FAMOTIDINE; LAFUTIDINE; STOMACH SECRETION INHIBITOR;

ADULT; AMBULATORY MONITORING; ARTICLE; CLINICAL ARTICLE; GASTRIC PH MONITORING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ACETAMIDES; ADULT; AGED; FAMOTIDINE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; PIPERIDINES; PYRIDINES; STOMACH;

EID: 34347338842     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1:1311-1315.
2. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-1131.
3. Doglioni C, Wotherspoon AC, Moschini A, de Boni M, Isaacson PG: High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992; 339:834-835.
4. Graham DY: Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997; 113:1983-1991.
5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K. Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of a gastric cancer. N Engl J Med 2001; 345:829-832.
6. Iijima K, Ohara S, Sekine H, Koike T, Kato K, Asaki S, Shimosegawa T, Toyota T: Changes in gastric acid secretion assayed by endoscopic gastrin test before and after H. pylori eradication. Gut 2000; 46:20-26.
7. Moss SF, Calam J: Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993; 34:888-892.
8. Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY: Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gatroenterol 1997; 32:664-668.
9. El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE: Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109:681-691.
10. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE: Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113:15-24.
11. Yasunaga Y, Shinomura Y, Kanayama S, Yabu M, Nakanishi T, Miyazaki Y, Murayama Y, Bonilla-Pala cios JJ, Matsuzawa Y: Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994; 35:1571-1574.
12. Gledhill T, Leicester RJ, Addis B, Lightfoot N, Barnard J, Viney N, Darkin D, Hunt RH: Epidemic hypochlorhydria. Br Med J 1985; 290:1383-1386.
13. Morris A, Nicholson G: Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82:192-199.
14. Sobala GM, Crabtree JE, Dixon MF, Schorah CJ, Taylor JD, Rathbone BJ, Heatley RV, Axon AT: Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 1991; 32:1415-1418.
15. Katelaris PH, Seow F, Lin BP, Napoli J, Ngu MC, Jones DB: Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 1993; 34:1032-1037.
16. Verdu EF, Armstrong D, Fraser R, Viani F, Idstrom JP, Cederberg C, Blum AL: Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995; 36:539-543.
17. Verdu EF, Armstrong D, Idstrom JP, Labenz J, Stolte M, Dorta G, Borsch G, Blum AL: Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995; 37:743-748.
18. Labenz J, Tillenburg B, Peitz U, Verdu E, Stolte M, Borsch G, Blum AL: Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer. Gut 1997; 41:33-36.
19. Van Herwaarden MA, Samsom M, Van Nispen CH, Mulder PG, Smout AJ: The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine. Aliment Pharmacol Ther 1999; 13:731-740.
20. Reilly TG, Mann SG, Panos MZ, Walt RP: Low-dose famotidine and cimetidine in single postprandial doses: a placebo-controlled comparative study of overnight pH. Gut 1995; 37:325-328.
21. Reilly TG, Singh S, Cottrell J, Mann SG, Stauffer L, Walt RP: Low-dose famotidine and ranitidine as single postprandial doses: a 3-period placebo-controlled comparative trial. Aliment Pharmacol Ther 1996; 10:749-755.
22. Grimley CE, Cottrell J, Mann SG, Stauffer L Walt RP: Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo. Aliment Pharmacol Ther 1997; 11:881-885.
23. Grimley CE, West JM, Loft DE, Cottrell J, Mann SG, Stauffer L, Nwokolo CU: Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man. Aliment Pharmacol Ther 1996; 10:743-747.
24. 2 receptor. Digestion 2001; 64:155-160.
25. 2-receptor antagonist. Aliment Pharmacol Ther 2003; 18:1149-1157.
26. Ohara S, Kato M, Asaka M, Toyota T: Studies of 13C-urea breath test for diagnosis of Helicobacter pylori infection in Japan. J Gastroenterol 1998; 33:6-13.
27. Ohara S, Kato M, Asaka M Toyota T: The UBit-100 13CO2 infrared analyzer: Comparison between infrared analyzer spectrometric analysis and mass spectrometric analysis. Helicobacter 1998; 3:49-53.
28. Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI Zhao X, Atherton JC, Blaser MJ: Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995; 73:760-770.
29. Vicari JJ, Peek RM, Falk GW, Goldblum JR, Easley KA, Schnell J, Perez-Perez GI, Halter SA, Rice TW, Blaser MJ, Richter JE: The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115:50-57.
30. El-Omar EM, Carrinagton M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402.
31. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H: Effect of interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123:92-105.
32. Boren T, Falk P, Roth KA, Larson G, Normark S: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262:1892-1895.
33. Azuma T, Konishi J, Tanaka Y, Hirai M, Ito S, Kato T, Kohli Y: Contribution of HLA-DQA gene to host's response against Helicobacter pylori. Lancet 1994; 343:542-543.
34. Kimura K: Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972; 63:584-592.
35. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazawa T, Miki K, Graham DY: Relationship of Helicobacter pylori to serum pepsinogen in asymptomatic Japanese population. Gastroenterology 1992; 102:760-766.
36. Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, Toyota T, Shimosegawa T: Helicobacter pylori infection prevents erosive reflux oesophagitis by decresing gastric acid secretion. Gut 2001; 49:330-334.